vs
Burke & Herbert Financial Services Corp.（BHRB）与RIGEL PHARMACEUTICALS INC（RIGL）财务数据对比。点击上方公司名可切换其他公司
Burke & Herbert Financial Services Corp.的季度营收约是RIGEL PHARMACEUTICALS INC的1.2倍（$86.5M vs $69.8M），RIGEL PHARMACEUTICALS INC净利率更高（384.0% vs 34.9%，领先349.1%），RIGEL PHARMACEUTICALS INC同比增速更快（21.2% vs 4.9%），过去两年Burke & Herbert Financial Services Corp.的营收复合增速更高（81.1% vs 53.7%）
伯克赫伯特金融服务公司是美国区域型金融控股企业，主营个人与商业银行业务、财富管理、住房抵押贷款、小微企业融资服务，核心市场覆盖弗吉尼亚州及大西洋沿岸中部邻近区域，服务零售客户、中小企业及高净值人群。
Rigel制药是一家临床阶段生物技术企业，专注于研发及商业化针对自身免疫性疾病、炎症性疾病与血液疾病的靶向小分子疗法，核心市场位于美国，旗下已获批产品可治疗成人免疫性血小板减少症，致力于满足未被覆盖的临床医疗需求。
BHRB vs RIGL — 直观对比
营收规模更大
BHRB
是对方的1.2倍
$69.8M
营收增速更快
RIGL
高出16.3%
4.9%
净利率更高
RIGL
高出349.1%
34.9%
两年增速更快
BHRB
近两年复合增速
53.7%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $86.5M | $69.8M |
| 净利润 | $30.2M | $268.1M |
| 毛利率 | — | 91.5% |
| 营业利润率 | 43.8% | 33.2% |
| 净利率 | 34.9% | 384.0% |
| 营收同比 | 4.9% | 21.2% |
| 净利润同比 | 52.8% | 1769.2% |
| 每股收益（稀释后） | $1.98 | $14.11 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收BHRBRIGL
| Q4 25 | $86.5M | $69.8M | ||
| Q3 25 | $85.4M | $69.5M | ||
| Q2 25 | $87.1M | $101.7M | ||
| Q1 25 | $83.0M | $53.3M | ||
| Q4 24 | $82.5M | $57.6M | ||
| Q3 24 | $83.8M | $55.3M | ||
| Q2 24 | $69.3M | $36.8M | ||
| Q1 24 | $26.4M | $29.5M |
净利润BHRBRIGL
| Q4 25 | $30.2M | $268.1M | ||
| Q3 25 | $30.0M | $27.9M | ||
| Q2 25 | $29.9M | $59.6M | ||
| Q1 25 | $27.2M | $11.4M | ||
| Q4 24 | $19.8M | $14.3M | ||
| Q3 24 | $27.6M | $12.4M | ||
| Q2 24 | $-16.9M | $-1.0M | ||
| Q1 24 | $5.2M | $-8.2M |
毛利率BHRBRIGL
| Q4 25 | — | 91.5% | ||
| Q3 25 | — | 93.2% | ||
| Q2 25 | — | 95.6% | ||
| Q1 25 | — | 91.7% | ||
| Q4 24 | — | 89.9% | ||
| Q3 24 | — | 85.5% | ||
| Q2 24 | — | 92.4% | ||
| Q1 24 | — | 93.1% |
营业利润率BHRBRIGL
| Q4 25 | 43.8% | 33.2% | ||
| Q3 25 | 43.3% | 40.9% | ||
| Q2 25 | 42.7% | 60.1% | ||
| Q1 25 | 39.6% | 23.9% | ||
| Q4 24 | 24.6% | 28.9% | ||
| Q3 24 | 39.2% | 25.4% | ||
| Q2 24 | -27.5% | 1.2% | ||
| Q1 24 | 22.3% | -23.6% |
净利率BHRBRIGL
| Q4 25 | 34.9% | 384.0% | ||
| Q3 25 | 35.1% | 40.2% | ||
| Q2 25 | 34.3% | 58.6% | ||
| Q1 25 | 32.8% | 21.5% | ||
| Q4 24 | 24.0% | 24.9% | ||
| Q3 24 | 33.0% | 22.5% | ||
| Q2 24 | -24.4% | -2.8% | ||
| Q1 24 | 19.8% | -27.9% |
每股收益（稀释后）BHRBRIGL
| Q4 25 | $1.98 | $14.11 | ||
| Q3 25 | $1.97 | $1.46 | ||
| Q2 25 | $1.97 | $3.28 | ||
| Q1 25 | $1.80 | $0.63 | ||
| Q4 24 | $1.72 | $0.82 | ||
| Q3 24 | $1.82 | $0.70 | ||
| Q2 24 | $-1.41 | $-0.06 | ||
| Q1 24 | $0.69 | $-0.47 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $155.0M |
| 总债务越低越好 | — | $52.5M |
| 股东权益账面价值 | $854.6M | $391.5M |
| 总资产 | $7.9B | $513.6M |
| 负债/权益比越低杠杆越低 | — | 0.13× |
8季度趋势，按日历期对齐
现金及短期投资BHRBRIGL
| Q4 25 | — | $155.0M | ||
| Q3 25 | — | $137.1M | ||
| Q2 25 | — | $108.4M | ||
| Q1 25 | — | $77.1M | ||
| Q4 24 | — | $77.3M | ||
| Q3 24 | — | $61.1M | ||
| Q2 24 | — | $49.1M | ||
| Q1 24 | — | $49.5M |
总债务BHRBRIGL
| Q4 25 | — | $52.5M | ||
| Q3 25 | — | $60.0M | ||
| Q2 25 | — | $60.0M | ||
| Q1 25 | — | $60.0M | ||
| Q4 24 | — | $60.0M | ||
| Q3 24 | — | $60.0M | ||
| Q2 24 | — | $60.0M | ||
| Q1 24 | — | $60.0M |
股东权益BHRBRIGL
| Q4 25 | $854.6M | $391.5M | ||
| Q3 25 | $822.2M | $117.6M | ||
| Q2 25 | $780.0M | $81.9M | ||
| Q1 25 | $758.0M | $18.6M | ||
| Q4 24 | $730.2M | $3.3M | ||
| Q3 24 | $738.1M | $-14.6M | ||
| Q2 24 | $693.1M | $-29.9M | ||
| Q1 24 | $319.3M | $-31.7M |
总资产BHRBRIGL
| Q4 25 | $7.9B | $513.6M | ||
| Q3 25 | $7.9B | $242.5M | ||
| Q2 25 | $8.1B | $206.7M | ||
| Q1 25 | $7.8B | $176.0M | ||
| Q4 24 | $7.8B | $164.0M | ||
| Q3 24 | $7.9B | $139.4M | ||
| Q2 24 | $7.8B | $128.4M | ||
| Q1 24 | $3.7B | $126.5M |
负债/权益比BHRBRIGL
| Q4 25 | — | 0.13× | ||
| Q3 25 | — | 0.51× | ||
| Q2 25 | — | 0.73× | ||
| Q1 25 | — | 3.23× | ||
| Q4 24 | — | 18.25× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $107.9M | $22.0M |
| 自由现金流经营现金流 - 资本支出 | $96.2M | — |
| 自由现金流率自由现金流/营收 | 111.2% | — |
| 资本支出强度资本支出/营收 | 13.5% | — |
| 现金转化率经营现金流/净利润 | 3.57× | 0.08× |
| 过去12个月自由现金流最近4个季度 | $164.1M | — |
8季度趋势，按日历期对齐
经营现金流BHRBRIGL
| Q4 25 | $107.9M | $22.0M | ||
| Q3 25 | $39.3M | $24.0M | ||
| Q2 25 | $41.0K | $30.5M | ||
| Q1 25 | $37.6M | $-893.0K | ||
| Q4 24 | $85.8M | $14.5M | ||
| Q3 24 | $47.8M | $21.7M | ||
| Q2 24 | $-46.0M | $302.0K | ||
| Q1 24 | $7.1M | $-5.0M |
自由现金流BHRBRIGL
| Q4 25 | $96.2M | — | ||
| Q3 25 | $35.4M | — | ||
| Q2 25 | $-3.4M | — | ||
| Q1 25 | $35.9M | — | ||
| Q4 24 | $81.2M | — | ||
| Q3 24 | $46.0M | — | ||
| Q2 24 | $-47.0M | — | ||
| Q1 24 | $5.6M | — |
自由现金流率BHRBRIGL
| Q4 25 | 111.2% | — | ||
| Q3 25 | 41.5% | — | ||
| Q2 25 | -3.9% | — | ||
| Q1 25 | 43.2% | — | ||
| Q4 24 | 98.5% | — | ||
| Q3 24 | 55.0% | — | ||
| Q2 24 | -67.8% | — | ||
| Q1 24 | 21.2% | — |
资本支出强度BHRBRIGL
| Q4 25 | 13.5% | — | ||
| Q3 25 | 4.5% | — | ||
| Q2 25 | 3.9% | — | ||
| Q1 25 | 2.1% | — | ||
| Q4 24 | 5.5% | — | ||
| Q3 24 | 2.1% | — | ||
| Q2 24 | 1.5% | — | ||
| Q1 24 | 5.7% | — |
现金转化率BHRBRIGL
| Q4 25 | 3.57× | 0.08× | ||
| Q3 25 | 1.31× | 0.86× | ||
| Q2 25 | 0.00× | 0.51× | ||
| Q1 25 | 1.38× | -0.08× | ||
| Q4 24 | 4.33× | 1.01× | ||
| Q3 24 | 1.73× | 1.75× | ||
| Q2 24 | — | — | ||
| Q1 24 | 1.36× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
